Pharmaceutical Preparation Manufacturing contractors at the Department of Veterans Affairs
- Latest 12 months
- $12.2B
- Net obligations · Up $852.4M vs. $11.3B preceding
- Prime contractors
- 156
- With positive obligations in the latest 12 months
Market snapshot for Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs
Federal records show $48.1B in net obligations across 6,474 awards in Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs from Oct 1, 2021 through Jul 27, 2026. This market accounts for 15.2% of $316.4B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 7.5% from $11.3B to $12.2B. 1 prime contractor accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $8.3B | 2,193 | Complete |
| FY2023 | $9.4B | 2,088 | Complete |
| FY2024 | $8.8B | 2,417 | Complete |
| FY2025 | $11.7B | 2,089 | Complete |
| FY2026 | $9.9B | 1,750 | YTD through Jul 27, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $48.1B
- 6,474 awards · 351 prime contractors
- Latest 12-month movement
- +7.5%
- $12.2B vs. $11.3B
- Leading eight prime share
- 99.3%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 15.2% of $316.4B in agency-wide net obligations.
- Set-aside share when reported
- 33.6% of 2,482 awards with reported set-aside status.
- Set-aside reporting
- 835 set aside · 1,647 no set-aside · 3,992 not reported
What changed in the last 12 months?
Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.
Market structure
Reported set-aside share decreased
Award activity
MCKESSON CORPORATION received an unusually large obligation action
Buyer demand
Reported obligations through VHA CHIEF LOGISTICS OFFICE (36C240) increased
Competitive shifts
MCKESSON CORPORATION had the largest increase in reported obligations
EXELAN PHARMACEUTICALS INC climbed the most in the contractor rankings
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Funding pattern for Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs
See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.
97.6% of positive obligations were attributed to VHA CHIEF LOGISTICS OFFICE (36C240). That represents $11.9B, up $774.6M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- VHA CHIEF LOGISTICS OFFICE (36C240)97.6% · $11.9B · up $774.6M
- 242-NETWORK CONTRACT OFFICE 02 (36C242)0.090% · $10.7M · up $6.7M
- 541-BRECKSVILLE (00541)0.090% · $10.5M · up $6.6M
- 691-VA GREATER LA HLTHCR SYS(00691)0.070% · $9.1M · up $1.1M
- 578-HINES(00578)(36C578)0.060% · $7.7M · up $4.9M
- All other reported offices2.1% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
VHA CHIEF LOGISTICS OFFICE (36C240)
#1Rank unchangedLatest 12 months
$11.9B
97.6% of positive obligations
Versus preceding 12 months
+$774.6M
1 active prime contractor · 10 awards
View office comparison and evidence
Reported obligations increased 7.0% from $11.1B to $11.9B. The office’s share of positive obligations moved from 98.1% to 97.6%, a change of −0.5 percentage points.
The latest period contains 10 actions across 10 awards. The preceding period contained 1 active prime contractor and 12 awards.
Leading award-level changes
- MCKESSON CORPORATION · PIID 36C24026K1002+$1.4B: $0 → $1.4B
- MCKESSON CORPORATION · PIID 36C24026K1008+$1.4B: $0 → $1.4B
Reported funding office
242-NETWORK CONTRACT OFFICE 02 (36C242)
#2Up 13 from #15Latest 12 months
$10.7M
0.090% of positive obligations
Versus preceding 12 months
+$6.7M
9 active prime contractors · 15 awards
View office comparison and evidence
Reported obligations increased 168.6% from $4.0M to $10.7M. The office’s share of positive obligations moved from 0.040% to 0.090%, a change of +0.1 percentage points.
The latest period contains 22 actions across 15 awards and 4 newly active prime contractors. The preceding period contained 9 active prime contractors and 16 awards.
Reported funding office
541-BRECKSVILLE (00541)
#3Up 13 from #16Latest 12 months
$10.5M
0.090% of positive obligations
Versus preceding 12 months
+$6.6M
14 active prime contractors · 27 awards
View office comparison and evidence
Reported obligations increased 168.1% from $3.9M to $10.5M. The office’s share of positive obligations moved from 0.030% to 0.090%, a change of +0.1 percentage points.
The latest period contains 37 actions across 27 awards and 6 newly active prime contractors. The preceding period contained 10 active prime contractors and 14 awards.
Reported funding office
691-VA GREATER LA HLTHCR SYS(00691)
#4Up 2 from #6Latest 12 months
$9.1M
0.070% of positive obligations
Versus preceding 12 months
+$1.1M
16 active prime contractors · 22 awards
View office comparison and evidence
Reported obligations increased 13.7% from $8.0M to $9.1M. The office’s share of positive obligations moved from 0.070% to 0.070%, a change of 0.0 percentage points.
The latest period contains 33 actions across 22 awards and 4 newly active prime contractors. The preceding period contained 15 active prime contractors and 22 awards.
Reported funding office
578-HINES(00578)(36C578)
#5Up 20 from #25Latest 12 months
$7.7M
0.060% of positive obligations
Versus preceding 12 months
+$4.9M
15 active prime contractors · 25 awards
View office comparison and evidence
Reported obligations increased 176.3% from $2.8M to $7.7M. The office’s share of positive obligations moved from 0.020% to 0.060%, a change of 0.0 percentage points.
The latest period contains 36 actions across 25 awards and 7 newly active prime contractors. The preceding period contained 9 active prime contractors and 20 awards.
Reported funding office
NATIONAL CMOP OFFICE (36C770)
#6Down 4 from #2Latest 12 months
$7.7M
0.060% of positive obligations
Versus preceding 12 months
−$10.7M
15 active prime contractors · 22 awards
View office comparison and evidence
Reported obligations decreased 58.2% from $18.3M to $7.7M. The office’s share of positive obligations moved from 0.16% to 0.060%, a change of −0.1 percentage points.
The latest period contains 28 actions across 22 awards and 3 newly active prime contractors. The preceding period contained 25 active prime contractors and 69 awards.
Reported funding office
626-NASHVILLE (00626)
#7Down 3 from #4Latest 12 months
$6.8M
0.060% of positive obligations
Versus preceding 12 months
−$3.2M
10 active prime contractors · 35 awards
View office comparison and evidence
Reported obligations decreased 31.8% from $10.0M to $6.8M. The office’s share of positive obligations moved from 0.090% to 0.060%, a change of 0.0 percentage points.
The latest period contains 39 actions across 35 awards and 3 newly active prime contractors. The preceding period contained 13 active prime contractors and 54 awards.
Reported funding office
549-DALLAS (00549)
#8Down 1 from #7Latest 12 months
$6.8M
0.060% of positive obligations
Versus preceding 12 months
−$201K
11 active prime contractors · 24 awards
View office comparison and evidence
Reported obligations decreased 2.9% from $7.0M to $6.8M. The office’s share of positive obligations moved from 0.060% to 0.060%, a change of 0.0 percentage points.
The latest period contains 37 actions across 24 awards and 1 newly active prime contractor. The preceding period contained 12 active prime contractors and 23 awards.
Reported funding office
VETERANS HEALTH ADMINISTRATION
#9Up 30 from #39Latest 12 months
$6.4M
0.050% of positive obligations
Versus preceding 12 months
+$4.7M
7 active prime contractors · 8 awards
View office comparison and evidence
Reported obligations increased 273.0% from $1.7M to $6.4M. The office’s share of positive obligations moved from 0.020% to 0.050%, a change of 0.0 percentage points.
The latest period contains 8 actions across 8 awards and 5 newly active prime contractors. The preceding period contained 3 active prime contractors and 7 awards.
Reported funding office
261-NETWORK CONTRACT OFFICE 21 (36C261)
#10Up 11 from #21Latest 12 months
$6.3M
0.050% of positive obligations
Versus preceding 12 months
+$3.2M
31 active prime contractors · 70 awards
View office comparison and evidence
Reported obligations increased 104.3% from $3.1M to $6.3M. The office’s share of positive obligations moved from 0.030% to 0.050%, a change of 0.0 percentage points.
The latest period contains 86 actions across 70 awards and 10 newly active prime contractors. The preceding period contained 29 active prime contractors and 67 awards.
Reported funding office
521-BIRMINGHAM(00521)(36C521)
#13New to the positive-obligation rankingLatest 12 months
$5.8M
0.050% of positive obligations
Versus preceding 12 months
+$6.1M
5 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations moved from $325K in net deobligations to $5.8M in net obligations. The office’s share of positive obligations moved from 0% to 0.050%, a change of +0.1 percentage points.
The latest period contains 17 actions across 5 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 5 awards.
Reported funding office
652-RICHMOND(00652)(36C652)
#16Up 88 from #104Latest 12 months
$5.1M
0.040% of positive obligations
Versus preceding 12 months
+$5.0M
5 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations increased 3375.4% from $147K to $5.1M. The office’s share of positive obligations moved from 0% to 0.040%, a change of 0.0 percentage points.
The latest period contains 12 actions across 7 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 7 awards.
Reported funding office
548-WEST PALM (00548)(36C548)
#45Down 36 from #9Latest 12 months
$2.6M
0.020% of positive obligations
Versus preceding 12 months
−$3.8M
6 active prime contractors · 14 awards
View office comparison and evidence
Reported obligations decreased 59.5% from $6.4M to $2.6M. The office’s share of positive obligations moved from 0.060% to 0.020%, a change of 0.0 percentage points.
The latest period contains 18 actions across 14 awards and 2 newly active prime contractors. The preceding period contained 5 active prime contractors and 15 awards.
Reported funding office
580-HOUSTON(00580)
#67Down 59 from #8Latest 12 months
$1.6M
0.010% of positive obligations
Versus preceding 12 months
−$4.9M
9 active prime contractors · 16 awards
View office comparison and evidence
Reported obligations decreased 75.6% from $6.5M to $1.6M. The office’s share of positive obligations moved from 0.060% to 0.010%, a change of −0.1 percentage points.
The latest period contains 26 actions across 16 awards and 1 newly active prime contractor. The preceding period contained 11 active prime contractors and 14 awards.
Reported funding office
VA CMOP TUCSON (00762)
#88Down 85 from #3Latest 12 months
$960K
0.010% of positive obligations
Versus preceding 12 months
−$11.8M
8 active prime contractors · 12 awards
View office comparison and evidence
Reported obligations decreased 92.5% from $12.8M to $960K. The office’s share of positive obligations moved from 0.11% to 0.010%, a change of −0.1 percentage points.
The latest period contains 13 actions across 12 awards and 2 newly active prime contractors. The preceding period contained 14 active prime contractors and 32 awards.
Leading award-level changes
- FFF ENTERPRISES, INC. · PIID 36C77024C0001−$10.2M: $10.2M → $0
- PHARMACY BUYING ASSOCIATION, INC. · PIID 36C77025P0033−$403K: $403K → $0
Reported funding office
NAC PHARMACEUTICALS (36E797)
#122Down 117 from #5Latest 12 months
$52K
0% of positive obligations
Versus preceding 12 months
−$8.4M
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations decreased 99.4% from $8.5M to $52K. The office’s share of positive obligations moved from 0.070% to 0%, a change of −0.1 percentage points.
The latest period contains 2 actions across 2 awards. The preceding period contained 2 active prime contractors and 38 awards.
How this work is bought
Reported award structure, competition, pricing, work categories, and contracting channels for Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs.
During Jul 28, 2025–Jul 27, 2026, this market recorded $12.2B in positive net award obligations across 1,144 awards. The leading reported procedure, Negotiated Proposal/Quote, accounted for 97.3% of that positive-obligation base. Awards with a reported parent IDV accounted for 99.5%.
- Leading award type
- 99.2%
- Delivery Order
- Leading reported procedure
- 97.3%
- Negotiated Proposal/Quote
- Reported parent IDV
- 99.5%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 850 of 1,144 awards reported offers
Same-NAICS comparison
Compared with the NAICS 325412 peer median, parent-IDV obligation share is 15.0 percentage points higher, reported full-and-open obligation share is 45.5 percentage points higher, delivery-order obligation share is 17.6 percentage points higher, and median positive award obligations are 394.6% higher.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 99.5% | 84.5% | +15.0 pts |
| Reported full-and-open obligation share | 99.0% | 53.5% | +45.5 pts |
| Delivery-order obligation share | 99.2% | 81.5% | +17.6 pts |
| Median positive award obligations | $60K | $12K | +394.6% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 739 | $12.1B | 99.2% |
| Purchase Order(B) | 301 | $54.5M | 0.45% |
| BPA Call(A) | 92 | $45.8M | 0.38% |
| Definitive Contract(D) | 12 | $3.0M | 0.020% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 231 | $11.9B | 97.7% |
| FSS(C) | 508 | $172.4M | 1.4% |
| BPA(E) | 92 | $45.8M | 0.38% |
| Not reported | 313 | $57.4M | 0.47% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 315 | $12.0B | 98.1% |
| Multiple Award(M) | 516 | $180.1M | 1.5% |
| Not reported | 313 | $57.4M | 0.47% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 73 | $11.9B | 97.3% |
| Subject To Multiple Award Fair Opportunity(MAFO) | 583 | $219.0M | 1.8% |
| Simplified Acquisition(SP1) | 347 | $84.0M | 0.69% |
| Only One Source(SSS) | 141 | $21.0M | 0.17% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full And Open Competition(A) | 641 | $12.1B | 99.0% |
| Competed Under SAP(F) | 249 | $81.2M | 0.66% |
| Not Competed(C) | 137 | $20.7M | 0.17% |
| Not Competed Under SAP(G) | 104 | $10.3M | 0.080% |
| Full And Open Competition After Exclusion Of Sources(D) | 9 | $3.1M | 0.030% |
| Not Available For Competition(B) | 4 | $273K | 0% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 428 | $116.1M | 0.95% |
| Fair Opportunity Given(FAIR) | 116 | $91.3M | 0.75% |
| Competitive Set Aside(CSA) | 6 | $7.0M | 0.060% |
| Urgency(URG) | 30 | $3.2M | 0.030% |
| Other Statutory Authority(OSA) | 3 | $1.5M | 0.010% |
| Not reported | 561 | $12.0B | 98.2% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 114 | $16.9M | 0.14% |
| SAP Non-Competition (FAR 13)(SP2) | 64 | $8.7M | 0.070% |
| Urgency (FAR 6.302-2)(URG) | 21 | $3.8M | 0.030% |
| Authorized By Statute (FAR 6.302-5(A)(2)(I))(OTH) | 42 | $1.9M | 0.020% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 2 | $60K | 0% |
| Less Than Or Equal To The Micro-Purchase Threshold(MPT) | 2 | $5K | 0% |
| Not reported | 899 | $12.2B | 99.7% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 1,142 | $12.2B | 100.0% |
| Fixed Price With Economic Price Adjustment(K) | 2 | $784K | 0.010% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs And Biologicals(6505) | 1,029 | $12.2B | 99.8% |
| Medical And Surgical Instruments, Equipment, And Supplies(6515) | 25 | $8.1M | 0.070% |
| Pharmacy Services(Q517) | 32 | $6.2M | 0.050% |
| Medical- Nuclear Medicine(Q527) | 13 | $3.3M | 0.030% |
| Imaging Equipment And Supplies: Medical, Dental, Veterinary(6525) | 8 | $2.2M | 0.020% |
| Chemical And Pharmaceutical Products Manufacturing Machinery(3650) | 9 | $1.3M | 0.010% |
| Other reported values | 28 | $4.6M | 0.037% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of Veterans Affairs(3600) | 1,144 | $12.2B | 100.0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Vha Chief Logistics Office (36c240)(36C240) | 10 | $11.9B | 97.2% |
| 262-Network Contract Office 22 (36c262)(36C262) | 77 | $40.7M | 0.33% |
| 246-Network Contracting Office 6 (36c246)(36C246) | 30 | $30.8M | 0.25% |
| 250-Network Contract Office 10 (36c250)(36C250) | 52 | $25.7M | 0.21% |
| 252-Network Contract Office 12 (36c252)(36C252) | 47 | $25.2M | 0.21% |
| 248-Network Contract Office 8 (36c248)(36C248) | 40 | $25.2M | 0.21% |
| Other reported values | 888 | $200.9M | 1.6% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 36W79720D0001(3600) | 11 | $11.9B | 97.2% |
| 36F79720D0227(3600) | 56 | $75.0M | 0.61% |
| 36F79720D0180(3600) | 38 | $33.9M | 0.28% |
| 36F79725D0093(3600) | 27 | $22.7M | 0.19% |
| 36C26226A0006(3600) | 8 | $18.5M | 0.15% |
| 36F79719D0170(3600) | 16 | $8.1M | 0.070% |
| 36F79724D0101(3600) | 26 | $7.5M | 0.060% |
| 36C24823D0049(3600) | 3 | $5.5M | 0.040% |
| Other reported values | 646 | $120.0M | 0.98% |
| Not reported | 313 | $57.4M | 0.47% |
Exactly matched vehicle usage
- VA FSS Schedule 65IB
76 awards · 15 matched parent PIIDs
Evidence: 36F79719D0169, 36F79719D0170, 36F79720D0099, 36F79722D0165, 36F79723D0158, …
$11.7M · 0.10%
76 awards matched an unambiguous catalog vehicle PIID. Company membership is not used as evidence of award-channel usage.
Offers, award size, and timing
- Median reported offers
- 1 median
- 850 reported · 294 not reported
- Positive award obligations
- $60K median
- $18K–$306K middle 50%
- Reported performance period
- 181 days (~6 months) median
- 1,143 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Prime contractors for Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs
Latest 12-month concentration and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 1 of 156prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 97.5%of positive obligations in the last 12 months
- Leading four prime contractors
- 99.0%of positive obligations in the last 12 months
- Leading eight prime contractors
- 99.3%of positive obligations in the last 12 months
Based on $12.2B in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$11.9B
97.5%
Dollar movement
+$774.0M
vs. prior 12 months
Last 12mo awards
17 awards
18 actions
Historical and award details for MCKESSON CORPORATION
- Obligations: prior → latest
- $11.1B → $11.9B
- +7.0%
- Share: prior → latest
- 98.1% → 97.5%
- −0.6 percentage points
- All-period obligations
- $47.0B
- 97.7% of all-period positive obligations · 162 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 6 41 Not reported 11 12 Reported small business 0 0 All-period set-aside types
- 1 · Total small business
- #2
Last 12mo obligations
$107.7M
0.88%
Dollar movement
+$107.0M
vs. prior 12 months
Last 12mo awards
72 awards
104 actions
Historical and award details for EXELAN PHARMACEUTICALS INC
- Obligations: prior → latest
- $658K → $107.7M
- +16270.1%
- Share: prior → latest
- 0.010% → 0.88%
- +0.9 percentage points
- All-period obligations
- $111.6M
- 0.23% of all-period positive obligations · 97 awards
- Recorded activity
- Since Jun 21, 2022
- through Jul 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 7 0 Not reported 65 4 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$39.8M
0.33%
Dollar movement
+$11.5M
vs. prior 12 months
Last 12mo awards
73 awards
113 actions
Historical and award details for PROGENICS PHARMACEUTICALS INC
- Obligations: prior → latest
- $28.2M → $39.8M
- +40.8%
- Share: prior → latest
- 0.25% → 0.33%
- +0.1 percentage points
- All-period obligations
- $131.4M
- 0.27% of all-period positive obligations · 162 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 3 1 Reported no set-aside 0 3 Not reported 70 65 Reported small business 73 69 All-period set-aside types
- 7 · Total small business
- #4
Last 12mo obligations
$33.3M
0.27%
Dollar movement
+$27.7M
vs. prior 12 months
Last 12mo awards
43 awards
52 actions
Historical and award details for NOVARTIS PHARMACEUTICALS CORPORATION
- Obligations: prior → latest
- $5.6M → $33.3M
- +492.7%
- Share: prior → latest
- 0.050% → 0.27%
- +0.2 percentage points
- All-period obligations
- $38.9M
- 0.080% of all-period positive obligations · 50 awards
- Recorded activity
- Since Oct 22, 2021
- through Jul 17, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 43 8 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$17.2M
0.14%
Dollar movement
−$6.6M
vs. prior 12 months
Last 12mo awards
124 awards
172 actions
Historical and award details for CARDINAL HEALTH 414, LLC
- Obligations: prior → latest
- $23.8M → $17.2M
- −27.6%
- Share: prior → latest
- 0.21% → 0.14%
- −0.1 percentage points
- All-period obligations
- $103.0M
- 0.21% of all-period positive obligations · 389 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 34 53 Not reported 90 91 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$10.9M
0.090%
Dollar movement
+$6.5M
vs. prior 12 months
Last 12mo awards
33 awards
50 actions
Historical and award details for RLS (USA) INC.
- Obligations: prior → latest
- $4.4M → $10.9M
- +146.9%
- Share: prior → latest
- 0.040% → 0.090%
- +0.1 percentage points
- All-period obligations
- $23.0M
- 0.050% of all-period positive obligations · 61 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 4 4 Reported no set-aside 8 7 Not reported 21 14 Reported small business 26 22 All-period set-aside types
- 8 · Total small business
- #7
Last 12mo obligations
$8.2M
0.070%
Dollar movement
+$324K
vs. prior 12 months
Last 12mo awards
68 awards
75 actions
Historical and award details for BRISTOL-MYERS SQUIBB COMPANY
- Obligations: prior → latest
- $7.9M → $8.2M
- +4.1%
- Share: prior → latest
- 0.070% → 0.070%
- 0.0 percentage points
- All-period obligations
- $20.2M
- 0.040% of all-period positive obligations · 104 awards
- Recorded activity
- Since Mar 22, 2022
- through Jul 17, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 68 29 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$7.1M
0.060%
Dollar movement
−$2.5M
vs. prior 12 months
Last 12mo awards
31 awards
68 actions
Historical and award details for SOFIE CO.
- Obligations: prior → latest
- $9.6M → $7.1M
- −26.1%
- Share: prior → latest
- 0.080% → 0.060%
- 0.0 percentage points
- All-period obligations
- $44.0M
- 0.090% of all-period positive obligations · 77 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 3 Reported no set-aside 13 18 Not reported 16 11 Reported small business 29 30 All-period set-aside types
- 8 · Total small business
- #9
Last 12mo obligations
$5.8M
0.050%
Dollar movement
+$3.4M
vs. prior 12 months
Last 12mo awards
32 awards
55 actions
Historical and award details for PETNET SOLUTIONS, INC.
- Obligations: prior → latest
- $2.4M → $5.8M
- +145.9%
- Share: prior → latest
- 0.020% → 0.050%
- 0.0 percentage points
- All-period obligations
- $13.5M
- 0.030% of all-period positive obligations · 96 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 11 9 Not reported 21 22 Reported small business 5 10 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$4.1M
0.030%
Dollar movement
+$2.8M
vs. prior 12 months
Last 12mo awards
6 awards
11 actions
Historical and award details for NUCLEAR DIAGNOSTIC PRODUCTS, INC
- Obligations: prior → latest
- $1.3M → $4.1M
- +223.1%
- Share: prior → latest
- 0.010% → 0.030%
- 0.0 percentage points
- All-period obligations
- $8.4M
- 0.020% of all-period positive obligations · 24 awards
- Recorded activity
- Since Oct 1, 2021
- through May 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 1 0 Reported no set-aside 2 4 Not reported 3 8 Reported small business 6 12 All-period set-aside types
- 2 · Total small business
- #11
Last 12mo obligations
$3.8M
0.030%
Dollar movement
+$546K
vs. prior 12 months
Last 12mo awards
15 awards
23 actions
Historical and award details for BRACCO DIAGNOSTICS INC.
- Obligations: prior → latest
- $3.2M → $3.8M
- +16.9%
- Share: prior → latest
- 0.030% → 0.030%
- 0.0 percentage points
- All-period obligations
- $14.5M
- 0.030% of all-period positive obligations · 33 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 30, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 3 Not reported 12 6 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$3.8M
0.030%
Dollar movement
−$786K
vs. prior 12 months
Last 12mo awards
11 awards
13 actions
Historical and award details for PHARMACY BUYING ASSOCIATION, INC.
- Obligations: prior → latest
- $4.5M → $3.8M
- −17.3%
- Share: prior → latest
- 0.040% → 0.030%
- 0.0 percentage points
- All-period obligations
- $29.9M
- 0.060% of all-period positive obligations · 211 awards
- Recorded activity
- Since Oct 29, 2021
- through Jun 10, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 7 27 Reported no set-aside 4 8 Not reported 0 0 Reported small business 11 35 All-period set-aside types
- 130 · Total small business
- #13
Last 12mo obligations
$3.6M
0.030%
Dollar movement
−$561K
vs. prior 12 months
Last 12mo awards
62 awards
75 actions
Historical and award details for MEDI-PHYSICS, INC.
- Obligations: prior → latest
- $4.2M → $3.6M
- −13.5%
- Share: prior → latest
- 0.040% → 0.030%
- 0.0 percentage points
- All-period obligations
- $16.0M
- 0.030% of all-period positive obligations · 148 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 4 Not reported 59 44 Reported small business 0 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$3.5M
0.030%
Dollar movement
−$1.6M
vs. prior 12 months
Last 12mo awards
44 awards
58 actions
Historical and award details for JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.
- Obligations: prior → latest
- $5.1M → $3.5M
- −31.4%
- Share: prior → latest
- 0.050% → 0.030%
- 0.0 percentage points
- All-period obligations
- $17.0M
- 0.040% of all-period positive obligations · 71 awards
- Recorded activity
- Since Jan 28, 2022
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 1 Reported no set-aside 11 12 Not reported 33 22 Reported small business 15 12 All-period set-aside types
- 1 · Total small business
- #15
Last 12mo obligations
$3.5M
0.030%
Dollar movement
+$3.5M
vs. prior 12 months
Last 12mo awards
8 awards
11 actions
Historical and award details for OPTUM INFUSION SERVICES 308, LLC
- Obligations: prior → latest
- $0 → $3.5M
- Not comparable
- Share: prior → latest
- 0% → 0.030%
- 0.0 percentage points
- All-period obligations
- $3.5M
- 0.010% of all-period positive obligations · 8 awards
- Recorded activity
- Since Oct 1, 2025
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 0 Not reported 6 0 Reported small business 0 0 All-period set-aside types
None reported.
Award activity for Pharmaceutical Preparation Manufacturing at the Department of Veterans Affairs
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$1.4B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
Why it stands out
One action represented 11.6% of the market’s latest 12-month positive obligations.
At $1.4B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.4B
- Share of 12-month positive obligations
- 11.6%
Supporting data
- Prime contractor
- #1 · 97.5% share
- −0.6 percentage points · $774.0M net increase; action exceeded it by $632.8M
- Funding office
- #1 · 97.6% attributed share
- −0.5 percentage points · $774.6M net increase; action exceeded it by $632.3M
This action
+$1.4B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY
Why it stands out
One action represented 11.5% of the market’s latest 12-month positive obligations.
At $1.4B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.4B
- Share of 12-month positive obligations
- 11.5%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL
Why it stands out
One action represented 9.8% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.8%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
Why it stands out
One action represented 9.7% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.7%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER
Why it stands out
One action represented 9.7% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.7%
This action
+$1.2B
MCKESSON CORPORATION
VHA CHIEF LOGISTICS OFFICE (36C240)
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH
Why it stands out
One action represented 9.7% of the market’s latest 12-month positive obligations.
At $1.2B, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $1.2B
- Share of 12-month positive obligations
- 9.7%
View recent award activity by date (10)
- Action−$400KAward net obligations$261K
- Action+$229KAward net obligations$229K
- Action+$108KAward net obligations$577K
- Action−$85KAward net obligations$250K
- Action+$46KAward net obligations$46K
- Action−$44KAward net obligations$27K
- Action+$38KAward net obligations$38K
- Action+$180KAward net obligations$180K
- Action−$500KAward net obligations$2.5M
- Action+$250KAward net obligations$270K
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology